Founding Cohort 2026, 9 spots remaining · 50% off Founders Rate For Life →
Authoritize.ai
Back to Atlas
CRITICALPharmacy / Compounding

Farmakeio Outsourcing LLC

FDA issued a warning letter to Farmakeio Outsourcing LLC (Southlake, TX), a 503B-registered outsourcing facility, following a 2019 inspection that found the facility's compounded drug products failed to meet section 503B conditions. Key violations included inadequate adverse event reporting procedures, compounding testosterone pellets that may constitute essentially a copy of an approved drug (Testopel), and distributing unapproved new drugs and misbranded products lacking adequate directions for use. FDA demanded written corrective action within 15 working days and warned that failure to comply could result in seizure or injunction.

You do not have any FDA-approved applications on file for drug products that you compound.

your facility compounded Testosterone Pellets in 12.5 mg, 25 mg, 37.5 mg, 50 mg, 62.5 mg, 87.5 mg, 100 mg, and 200 mg strengths using the bulk drug substance Testosterone

their labeling fails to bear adequate directions for their intended uses causing them to be misbranded under section 502(f)(1) of the FDCA

Your SOP does not adequately define a serious adverse event consistent with the definition of serious adverse drug experience in 21 CFR 310.305(b)

Within fifteen (15) working days of receipt of this letter, please notify this office in writing of the specific steps that you have taken to address any violations.

Should you continue to compound and distribute drug products that do not meet the conditions of section 503B, the compounding and distribution of your drugs would be subject to the new drug approval requirement, the requirement to label drug products with adequate directions for use, and the Drug Supply Chain Security Act requirements.

Failure to adequately address any violations may result in legal action without further notice, including, without limitation, seizure and injunction.

Does your site contain similar claims?

The free site audit scans your whole site against every entry in this Atlas. Most pharmacy / compounding sites match 3-6 patterns.

Run my free site audit

Worried about one specific page, ad, or email? Paste it into the free Claim Checker and see what the FDA and FTC would flag, with the precedent next to each one. No email required.

Check specific copy in the Claim Checker